The good news is that it does not always progress and we can actually divide people up into those who are at low risk, intermediate risk, or high risk. If you have low risk smoldering myeloma, that’s almost the same risk of progression as what we call MGUS or monoclonalRead More →
While multiple myeloma doesn’t yet have a cure and can be fatal, patients’ life expectancies vary widely, according to Jens Hillengass, MD, Chief of Myeloma at Roswell Park Comprehensive Cancer Center. “I have seen patients live from several weeks to more than 20 years after being diagnosed,” Dr. Hillengass says.Read More →
To meet the definition of smoldering multiple myeloma, both of the following criteria must be met: Serum monoclonal protein (IgG or IgA) ≥30 g/L or urinary monoclonal protein ≥500 mg per 24 h and/or clonal bone marrow plasma cells 10–60% Absence of myeloma-defining events or amyloidosis. How often does MGUSRead More →